Clinical article · Acute care, Specialties, Medicines and results

Thrombocytopenia in hospital: recognising TTP, HIT and DIC before platelets are given

Written for
Hospital physicians, emergency doctors and residents
Reading time
7 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • Confirm a low platelet count on a blood film before acting on it, and look at its trajectory and timing.
  • Thrombocytopenia with schistocytes and haemolysis needs same-day haematology review and consideration of plasma exchange for TTP.
  • In suspected HIT with an intermediate or high 4Ts score, stop all heparin and start a non-heparin anticoagulant; warfarin waits until platelets recover.
  • DIC is treated by treating its cause, and the ISTH score is repeated because the picture changes quickly.
  • Platelet transfusion is avoided in TTP and HIT unless bleeding is life-threatening, and in DIC is guided by bleeding rather than the count.
  • In endemic areas, dengue, malaria, leptospirosis and scrub typhus are common causes of a falling count.

Start with the film and the trajectory

Thrombocytopenia is common in hospital, particularly in intensive care, where it is associated with bleeding, transfusion and worse outcomes [1]. Most cases are explained by sepsis, drugs, liver disease, dilution or consumption. The task is to pick out the few causes that need a specific and urgent response, because the usual reflex, a platelet transfusion, can do harm in them.

  1. Confirm the count on a blood film. Platelet clumping in EDTA causes a falsely low count; a repeat in a citrate tube settles the question.
  2. Look at the film for schistocytes, blasts, spherocytes and malaria parasites.
  3. Plot the count over time: the size of the fall and the day it began matter as much as the lowest value.
  4. Ask whether the patient is bleeding, clotting, or neither, and review every drug, including heparin flushes.

A quick sort by clinical clue

ClueThink ofFirst steps
Schistocytes, haemolysis, neurological or renal involvementTTP or another thrombotic microangiopathyLDH, haptoglobin, reticulocytes, ADAMTS13 before plasma, urgent haematology
Fall of more than half, 5 to 10 days after heparin, or new thrombosisHeparin-induced thrombocytopenia4Ts score, anti-PF4 immunoassay
Sepsis, trauma, obstetric emergency or cancer with prolonged PT and low fibrinogenDICISTH score, repeated; treat the cause
Isolated low count in a well patientImmune thrombocytopeniaFilm, exclude HIV, hepatitis C and drugs
Fever in an endemic areaDengue, malaria, leptospirosis, scrub typhusMalaria test, dengue NS1 or IgM by day of illness
PregnancyGestational thrombocytopenia, pre-eclampsia, HELLP, TTPBlood pressure, urine protein, liver tests, film

Thrombocytopenia occurs in about one in ten pregnancies, and separating the benign from the dangerous needs obstetric and haematology input together [12]. After a viper bite, venom-induced consumption coagulopathy can mimic DIC and needs antivenom rather than blood products alone.

TTP: a medical emergency

Thrombotic thrombocytopenic purpura is caused by severe ADAMTS13 deficiency and presents with microangiopathic haemolytic anaemia, thrombocytopenia and organ ischaemia. Early diagnosis and prompt plasma exchange are critical, but rapid ADAMTS13 testing is not available everywhere [5]. Thrombotic microangiopathy more often occurs with a coexisting condition, such as infection, malignant hypertension, pregnancy, drugs or autoimmune disease, than as primary TTP [4].

The PLASMIC score helps estimate the probability of severe ADAMTS13 deficiency while the result is awaited. It uses seven items: the platelet count, evidence of haemolysis, active cancer, solid-organ or stem cell transplant, the MCV, the INR and creatinine. Scores of this kind have limited specificity [5], so a high score supports urgent treatment rather than making the diagnosis. Management follows the ISTH guideline [3]: send ADAMTS13 before plasma is given, start plasma exchange urgently with immunosuppression, and use further agents as the guideline and local availability allow. Platelets are not transfused unless bleeding is life-threatening.

HIT: stop heparin, change anticoagulant

Heparin-induced thrombocytopenia is an immune reaction that typically causes a moderate fall in platelets 5 to 10 days after heparin is started, with a high risk of venous and arterial thrombosis [8]. The fall can come within a day when heparin was given in the previous few months. The 4Ts score adds points for the degree of thrombocytopenia, its timing, thrombosis and the absence of another cause. In a meta-analysis, a low score had a very high negative predictive value, while intermediate and high scores need laboratory confirmation [7].

  • With an intermediate or high score, stop all heparin, including flushes and heparin-coated lines, and start a non-heparin anticoagulant at the intensity the ASH guideline gives for HIT with or without thrombosis [6].
  • Send an anti-PF4 immunoassay, with a functional assay where available.
  • Do not start warfarin until platelets have recovered, and reverse it with vitamin K if it was already running.
  • Avoid platelet transfusion unless there is serious bleeding, and look for asymptomatic deep vein thrombosis.

DIC: treat the cause, score repeatedly

Disseminated intravascular coagulation is a clinical and laboratory diagnosis. The ISTH overt DIC score combines the platelet count, a fibrin-related marker such as D-dimer, prolongation of the prothrombin time and the fibrinogen level, and a score of 5 or more is compatible with overt DIC [9, 10]. The tests should be repeated, because the picture changes quickly. In sepsis, the sepsis-induced coagulopathy score was introduced to identify an earlier, compensated phase [10].

The cornerstone of treatment is the underlying condition: source control and antibiotics in sepsis, delivery and haemorrhage control in obstetric DIC, and treatment of the cancer or leukaemia. Platelets and plasma should not be given on laboratory results alone, but for bleeding or before invasive procedures [9]. Across settings, restrictive platelet transfusion strategies have not been shown to increase mortality or bleeding [11].

Traps

  • Transfusing platelets for a number in TTP or HIT.
  • Missing schistocytes because no one looked at the film.
  • Continuing heparin flushes or low molecular weight heparin once HIT is suspected.
  • Labelling a fall in platelets as sepsis and missing HIT, or the reverse.
  • Diagnosing primary immune thrombocytopenia without excluding secondary causes such as HIV, hepatitis C and drugs [2].
  • Calling a febrile thrombocytopenia viral fever without testing for malaria.

Local laboratory methods, the availability of ADAMTS13 and functional HIT assays, and national transfusion guidance differ. Local haematology protocols take precedence.

How Sana Health helps

Given the platelet count with its trend, the film report, coagulation screen, haemolysis markers and the drug history, the Haematology engine checks for TTP, HIT and DIC first. It calculates the PLASMIC, 4Ts and ISTH DIC scores with each input shown, states what should not be given, such as platelets in suspected TTP or warfarin in acute HIT, and sets out the anticoagulation or transfusion plan with doses adjusted for weight and renal function. References are read from PubMed when the question is asked.

Questions

How quickly does HIT develop after heparin is started?

Typically 5 to 10 days after the first exposure, with a fall in platelets that is usually moderate rather than profound. It can begin within a day if the patient had heparin in the previous few months, because antibodies are already present. A very early fall without previous exposure points to another cause.

What does the PLASMIC score include?

Seven features: the platelet count, evidence of haemolysis, the absence of active cancer, the absence of solid-organ or stem cell transplant, the MCV, the INR and creatinine. A high score makes severe ADAMTS13 deficiency likely and supports urgent plasma exchange while the result is awaited; it does not replace haematology input.

When is a platelet transfusion appropriate in DIC?

When the patient is bleeding or needs an invasive procedure and the count is low, rather than for a laboratory value alone. The underlying cause, such as sepsis, obstetric haemorrhage, trauma or malignancy, must be treated at the same time. Thresholds follow national and local transfusion guidance.

References

  1. The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review (opens in a new tab)Chest, 2011
  2. Updated international consensus report on the investigation and management of primary immune thrombocytopenia (opens in a new tab)Blood Adv, 2019
  3. 2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura (opens in a new tab)J Thromb Haemost, 2025
  4. Clinical Evaluation and Management of Thrombotic Microangiopathy (opens in a new tab)Arthritis Rheumatol, 2024
  5. Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models (opens in a new tab)Blood Rev, 2026
  6. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia (opens in a new tab)Blood Adv, 2018
  7. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis (opens in a new tab)Blood, 2012
  8. Heparin-induced thrombocytopenia complicating extracorporeal membrane oxygenation support: Review of the literature and alternative anticoagulants (opens in a new tab)J Thromb Haemost, 2019
  9. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology (opens in a new tab)Br J Haematol, 2009
  10. Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis (opens in a new tab)J Thromb Haemost, 2023
  11. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines (opens in a new tab)JAMA, 2025
  12. How I treat thrombocytopenia in pregnancy (opens in a new tab)Blood, 2024